NCT05794581CompletedPhase 1
A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
A Randomized, Double-Blind, Placebo and Comparator-Controlled Crossover Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
Source: ClinicalTrials.gov · Last updated 27 Dec 2024
Brief summary (registry, in English)
This study will be conducted primarily to evaluate the effects of CT-868 on glucose homeostasis in participants with Type 1 Diabetes Mellitus.
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 10 Mar 2023
- Start date
- 21 Mar 2023
- Primary completion date
- 6 Mar 2024
- Lead sponsor
- Carmot Therapeutics, Inc.
- Diseases
- Obesity, Type 1 diabetes
- NCT number
- NCT05794581
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 32
- From 21 Mar 2023 to the primary completion date, 6 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Uncontrolled diabetes
- History of surgical treatment for weight loss
- History of malignancy
Other
- Significant medical history
Who the study is looking for
- Female or male adults with Type 1 diabetes
- Ages 18-65 years
- Type 1 DM for at least 3 years
- Using an insulin pump or multiple daily injections (MDI) for at least 3 months
- BMI 25.0 - 35.0
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Carmot Clinical Research Unit 101 Coordinator of this site? Confirm its status | Chula Vista | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.